LIVONIA – Digital Insulin enhancement company, Hygieia, has cut a three-year deal with Blue Cross Blue Shield of Michigan to make its Nav Insulin Guidance Service available at no cost and with no co-pays to BCBSM members with Type 2 diabetes, starting with at-risk populations in Southeast Michigan. Financial terms were not disclosed.

The agreement is based largely on initial results from a Health Economic Evaluation  conducted among BCBSM members, which demonstrated that the d-Nav Service generates substantial cost savings – primarily by optimizing insulin therapy and the use of glycemic medications among people with Type 2 diabetes – while greatly improving clinical outcomes.

The Hygieia d-Nav Insulin Guidance Service combines smart cloud-based technology and a small team of healthcare professionals to support primary care physicians and help people with diabetes achieve improved health. The d-Nav Service provides personalized adjustments to enhance and simplify insulin dosing, maximizing its effectiveness for patients and the physicians who prescribe it. The Service has demonstrated ability to sustain hemoglobin A1c (HbA1c) reductions for at least five years.

Beginning this fall, the d-Nav Service will be available to all BCBSM members in Southeast Michigan who use insulin to treat their Type 2 diabetes and have an HbA1c above 7.0 percent. Clinical practice guidelines published by the American Diabetes Association generally point to HbA1c levels below 7 percent as reasonable targets to help prevent diabetes complications. BCBSM and Hygieia will explore opportunities to make the d-Nav Service available to other populations and markets in the near future.

More information is available at www.hygieia.com